Skip to content

The clinical study on the Taohong Siwu Decoction treating targeted drugs-induced hand-foot skin reaction

The clinical study on the Taohong Siwu Decoction treating anti-angiogenic drugs-induced hand-foot skin reaction (syndrome of wind-dryness due to blood deficiency) based on the theory of "the heart is manifested on surface"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001414
Enrollment
Unknown
Registered
2026-06-05
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anticancer targeted drugs-related skin side effects

Interventions

Trial group:Taohong Siwu Decoction plus urea ointment
Control group:placebo plus urea ointment

Sponsors

Fangshan Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 85 Years

Inclusion criteria

Inclusion criteria: (a) Patients pathologically diagnosed malignant tumor are treated by angiogenesis inhibitors, which belong to syndrome of wind-dryness due to blood deficiency; (b) age from 18 to 85 years old; (c) no severe organic dysfunction and auto-immune diseases; (d) patients understand the study and sign consent form.

Exclusion criteria

Exclusion criteria: (a) patients have other skin diseases or systemic disease with skin lesions; (b) patients are experiencing treatment for hand-foot skin reaction; (c) patients are predicted to discontinue anti-angiogenesis targeted drugs in 2 weeks; (d) antibiotics have been used within the past 3 months; (e) Terpenoid compounds such as carotenoids, camphor, rosin acids, menthol, borneol, or vitamin A were applied to the affected skin lesions in the past 7 days; (f) patients with allergic constitution; (g) Severe skin ulceration with concurrent infection.

Design outcomes

Primary

MeasureTime frame
Effective rate;

Secondary

MeasureTime frame
Pain assessment;Scope of skin lesion;Quality of life assessment;Dermoscopy evaluation;Analysis of skin microbiome;Safety evaluation;

Countries

China

Contacts

Public ContactPENG Yanmei

Fangshan Hospital Beijing University of Chinese Medicine

20160941139@bucm.edu.cn15210819252

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 29, 2026